Results 51 to 60 of about 9,671 (272)
Novel Perspectives in Pseudomyxoma Peritonei Treatment
Cancers, 2021 Simple Summary Pseudomyxoma Peritonei (PMP) represents a rare entity which greatly benefits from Cytoreductive Surgery (CRS) associated with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
A. Sommariva +5 more
semanticscholar +1 more source
Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man
Clinical Case Reports, 2021 Primary peritoneal mucinous adenocarcinoma is rare in men. The low‐grade tumor consisted of mucin‐producing columnar cells with minimal nuclear atypia. Relationship to pseudomyxoma peritonei and disseminated peritoneal adenomucinosis is discussed.
Fumiko Satoh, Yutaka Tsutusmi
doaj +1 more source
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
Journal for ImmunoTherapy of Cancer, 2021 Background Pseudomyxoma peritonei (PMP) is a rare, slow-growing abdominal cancer with no efficacious treatment options in non-resectable and recurrent cases. Otherwise, rare activating mutations in the GNAS oncogene are remarkably frequent in PMP and the
K. Flatmark +7 more
semanticscholar +1 more source
Pseudomyxoma pleurii: unusual location of a rare disease
Radiology Case Reports, 2021 Pseudomyxoma peritonei with pleural extension is very rare. Dissemination in the pleural cavity can be trans diaphragmatic or hematogenous. Appendicular and ovarian mucinous tumors are the most often involved.
Kaoutar Imrani +4 more
doaj
Pseudomyxoma peritonei – a revisit: report of 2 cases and literature review [PDF]
, 2006 BACKGROUND: Pseudomyxoma peritonei (PMP) is a rare, chronic, relapsing, diagnostically challenging and poorly understood disease characterized by disseminated mucinous ascites and peritoneal implants.
Kanthan, Rani +2 more
core +3 more sources
Frontiers in Surgery, 2021 Background: Pseudomyxoma peritonei (PMP) originating from appendiceal mucinous neoplasm is a rare peritoneal malignancy characterized by the progressive intraperitoneal accumulation of mucus leading to death if left untreated.
F. Santullo +8 more
semanticscholar +1 more source
Pseudomyxoma Peritonei in a Patient with History of Breast Cancer
The Korean Journal of Gastroenterology, 2016 Pseudomyxoma peritonei is a very rare condition, and even rarer in patients with history of cancer. A 70-year old woman with a history of breast cancer was admitted with abdominal pain and distention.
Tae Seob Jung +6 more
doaj +1 more source
International Journal of Cancer, 2021 Pseudomyxoma peritonei (PMP) is a rare disorder with unique pathological and genetic changes. Although several studies have reported the clinical features and mutational changes of PMP that originates from the appendix, few studies on PMP originating ...
B. Wang +15 more
semanticscholar +1 more source
CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI
Сибирский онкологический журнал, 2019 Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis accompanied by accumulation of mucus and high recurrence rate and in some cases complicated with intestinal obstruction.
A. G. Abdullaev +2 more
doaj +1 more source
Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin. [PDF]
, 2022 Peritoneal cancer (PC) is a dire finding, yet in selected patients, long-term survival is possible. Complete cytoreductive surgery (CRS) together with combination immunochemotherapy is essential to achieve cure. Hyperthermic intraperitoneal chemotherapy (
Adamina, M. +16 more
core +5 more sources